237 related articles for article (PubMed ID: 31250546)
1. Effect of sirolimus on coagulopathy of slow-flow vascular malformations.
Mack JM; Verkamp B; Richter GT; Nicholas R; Stewart K; Crary SE
Pediatr Blood Cancer; 2019 Oct; 66(10):e27896. PubMed ID: 31250546
[TBL] [Abstract][Full Text] [Related]
2. Association of localized intravascular coagulopathy with venous malformations.
Dompmartin A; Acher A; Thibon P; Tourbach S; Hermans C; Deneys V; Pocock B; Lequerrec A; Labbé D; Barrellier MT; Vanwijck R; Vikkula M; Boon LM
Arch Dermatol; 2008 Jul; 144(7):873-7. PubMed ID: 18645138
[TBL] [Abstract][Full Text] [Related]
3. MRI phenotypes of localized intravascular coagulopathy in venous malformations.
Koo KS; Dowd CF; Mathes EF; Rosbe KW; Hoffman WY; Frieden IJ; Hess CP
Pediatr Radiol; 2015 Oct; 45(11):1690-5. PubMed ID: 26143286
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series.
Mack JM; Richter GT; Crary SE
Lymphat Res Biol; 2018 Jun; 16(3):278-281. PubMed ID: 29583078
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations.
Binet Q; Lambert C; Hermans C
Thromb Res; 2018 Aug; 168():114-120. PubMed ID: 30064682
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study of hematologic complications in patients with slow-flow vascular malformations undergoing sclerotherapy.
Ricci KW; Chute C; Hammill AM; Dasgupta R; Patel M
Pediatr Blood Cancer; 2020 Oct; 67(10):e28277. PubMed ID: 32779831
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy and related complications following sclerotherapy of congenital venous malformations.
Swerdlin RF; Briones MA; Gill AE; Hawkins CM
Pediatr Blood Cancer; 2022 May; 69(5):e29610. PubMed ID: 35234344
[TBL] [Abstract][Full Text] [Related]
8. Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography.
Mack JM; Pierce CD; Richter GT; Spray BJ; Nicholas R; Lewis PS; Becton D; Crary SE
Pediatr Blood Cancer; 2021 Feb; 68(2):e28824. PubMed ID: 33211399
[TBL] [Abstract][Full Text] [Related]
9. Chronic localized intravascular coagulation complicating multifocal venous malformations.
Martin LK; Russell S; Wargon O
Australas J Dermatol; 2009 Nov; 50(4):276-80. PubMed ID: 19916972
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations.
Liu H; Hu L; Yang X; Xu Z; Gu H; Chen H; Lin X
J Vasc Surg Venous Lymphat Disord; 2023 Mar; 11(2):397-403.e1. PubMed ID: 36328137
[TBL] [Abstract][Full Text] [Related]
11. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients.
Mazoyer E; Enjolras O; Bisdorff A; Perdu J; Wassef M; Drouet L
Arch Dermatol; 2008 Jul; 144(7):861-7. PubMed ID: 18645137
[TBL] [Abstract][Full Text] [Related]
12. D-dimer level correlation with treatment response in children with venous malformations.
Leung YC; Leung MW; Yam SD; Hung JW; Liu CS; Chung LY; Tang MY; Fung HS; Poon WL; Chao NS; Liu KK
J Pediatr Surg; 2018 Feb; 53(2):289-292. PubMed ID: 29221638
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
[TBL] [Abstract][Full Text] [Related]
15. Extensive venous/lymphatic malformations causing life-threatening haematological complications.
Mazereeuw-Hautier J; Syed S; Leisner RI; Harper JI
Br J Dermatol; 2007 Sep; 157(3):558-63. PubMed ID: 17573883
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension in patients with slow-flow vascular malformations.
Rodríguez-Mañero M; Aguado L; Redondo P
Arch Dermatol; 2010 Dec; 146(12):1347-52. PubMed ID: 21173318
[TBL] [Abstract][Full Text] [Related]
17. How we approach coagulopathy with vascular anomalies.
Mack JM; Crary SE
Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e29353. PubMed ID: 36070211
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies.
Redondo P; Aguado L; Marquina M; Paramo JA; Sierra A; Sánchez-Ibarrola A; Martínez-Cuesta A; Cabrera J
Br J Dermatol; 2010 Feb; 162(2):350-6. PubMed ID: 19769632
[TBL] [Abstract][Full Text] [Related]
19. Elevated D-dimer level in the differential diagnosis of venous malformations.
Dompmartin A; Ballieux F; Thibon P; Lequerrec A; Hermans C; Clapuyt P; Barrellier MT; Hammer F; Labbé D; Vikkula M; Boon LM
Arch Dermatol; 2009 Nov; 145(11):1239-44. PubMed ID: 19917952
[TBL] [Abstract][Full Text] [Related]
20. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
